ANAB
ANAPTYSBIO, INC
ANAPTYSBIO, INC (ANAB) has 5 SEC Form 4 filings (19 transaction rows) in the rolling window, disclosed by 2 distinct insiders. Most recent filing: Jun 17, 2026.
Insiders have net sold $1.5M over the trailing 6 months.
- Industry:Biotechnology
- CEO:Daniel R. Faga
- Employees:136
- HQ:San Diego, CA, US
- IPO:2017-01-26
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$1.5M
reported sales (SEC code S)
Unique Insiders
2
in the rolling window
Market Cap
$1.7B
Price slightly stale
| Source | ||||||
|---|---|---|---|---|---|---|
Faga DanielFirst filing | President, CEO | Sale | 26,519 | $1.1M | Mar 27 | SEC ↗ |
LOUMEAU ERIC JFirst filing | CHIEF LEGAL OFFICER | Sale | 14,460 | $439K | Jan 8 | SEC ↗ |
Related companies
ANAPTYSBIO, INC is in the Healthcare sector.